Showing results (111-120 of 560) with videos related to
Sort By:
Pageof 56
Frontiers in Oncology|October 5, 2020
Diagnostic Accuracy and Safety of Coaxial System in Oncology Patients Treated in a Specialist Cancer Center With Prospective Validation Within Clinical Trial DataKhurum Khan, Reyes Gonzalez-Exposito, David Cunningham, et al.JCO Precision Oncology|March 9, 2022
Impact of Circulating Tumor DNA-Based Detection of Molecular Residual Disease on the Conduct and Design of Clinical Trials for Solid TumorsPashtoon M Kasi, Gordon Fehringer, Hiroya Taniguchi, et al.Clinical Colorectal Cancer|January 7, 2011
Predictive and prognostic biomarkers for targeted therapy in metastatic colorectal cancerUzma Asghar, Eliza Hawkes, David CunninghamClinical Lymphoma|November 19, 2002
Gemcitabine and its combinations in the treatment of malignant lymphomaIan Chau, David Watkins, David CunninghamThe Oncologist|July 4, 2013
Selecting patients with locally advanced rectal cancer for neoadjuvant treatment strategiesAlice Dewdney, David Cunningham, Ian ChauLeukemia & Lymphoma|January 7, 2006
Sub-clinical dissemination of follicular lymphoma in normal sized lymph nodes may not be detected by radiologic staging: a case of disseminated follicular lymphoma detected in nodal clearance as part of therapy for cutaneous melanomaMichael Dickinson, Andrew Wotherspoon, David CunninghamClinical Colorectal Cancer|June 5, 2003
Overview of preoperative and postoperative therapy for colorectal cancer: the European and United States perspectivesIan Chau, Samuel Chan, David CunninghamNature Reviews. Clinical Oncology|April 7, 2011
Targeting the human EGFR family in esophagogastric cancerAlicia Okines, David Cunningham, Ian ChauEuropean Journal of Cancer (Oxford, England : 1990)|June 15, 2010
Trastuzumab in gastric cancerAlicia F C Okines, David CunninghamCritical Reviews in Oncology/Hematology|February 27, 2003
Matrix metalloproteinase inhibitors--an emphasis on gastrointestinal malignanciesIan Chau, Anne Rigg, David CunninghamPageof 56